These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 29072699)

  • 1. CITED2 affects leukemic cell survival by interfering with p53 activation.
    Mattes K; Berger G; Geugien M; Vellenga E; Schepers H
    Cell Death Dis; 2017 Oct; 8(10):e3132. PubMed ID: 29072699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CITED2-mediated human hematopoietic stem cell maintenance is critical for acute myeloid leukemia.
    Korthuis PM; Berger G; Bakker B; Rozenveld-Geugien M; Jaques J; de Haan G; Schuringa JJ; Vellenga E; Schepers H
    Leukemia; 2015 Mar; 29(3):625-35. PubMed ID: 25184385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional regulators CITED2 and PU.1 cooperate in maintaining hematopoietic stem cells.
    Mattes K; Geugien M; Korthuis PM; Brouwers-Vos AZ; Fehrmann RSN; Todorova TI; Steidl U; Vellenga E; Schepers H
    Exp Hematol; 2019 May; 73():38-49.e7. PubMed ID: 30986495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CITED2 silencing sensitizes cancer cells to cisplatin by inhibiting p53 trans-activation and chromatin relaxation on the ERCC1 DNA repair gene.
    Liu YC; Chang PY; Chao CC
    Nucleic Acids Res; 2015 Dec; 43(22):10760-81. PubMed ID: 26384430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knockdown of CITED2 using short-hairpin RNA sensitizes cancer cells to cisplatin through stabilization of p53 and enhancement of p53-dependent apoptosis.
    Wu ZZ; Sun NK; Chao CC
    J Cell Physiol; 2011 Sep; 226(9):2415-28. PubMed ID: 21660965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockdown of Cbp/P300-interacting transactivator with Glu/Asp-rich carboxy-terminal domain 2 inhibits cell division and increases apoptosis in gastric cancer.
    Tang Z; He G; Xu J; Zhongfu L
    J Surg Res; 2017 May; 211():1-7. PubMed ID: 28501104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cited2 modulates TGF-beta-mediated upregulation of MMP9.
    Chou YT; Wang H; Chen Y; Danielpour D; Yang YC
    Oncogene; 2006 Sep; 25(40):5547-60. PubMed ID: 16619037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cited2 is an essential regulator of adult hematopoietic stem cells.
    Kranc KR; Schepers H; Rodrigues NP; Bamforth S; Villadsen E; Ferry H; Bouriez-Jones T; Sigvardsson M; Bhattacharya S; Jacobsen SE; Enver T
    Cell Stem Cell; 2009 Dec; 5(6):659-65. PubMed ID: 19951693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CITED2 controls the hypoxic signaling by snatching p300 from the two distinct activation domains of HIF-1α.
    Yoon H; Lim JH; Cho CH; Huang LE; Park JW
    Biochim Biophys Acta; 2011 Dec; 1813(12):2008-16. PubMed ID: 21925214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High Glucose-Repressed CITED2 Expression Through miR-200b Triggers the Unfolded Protein Response and Endoplasmic Reticulum Stress.
    Gu H; Yu J; Dong D; Zhou Q; Wang JY; Fang S; Yang P
    Diabetes; 2016 Jan; 65(1):149-63. PubMed ID: 26450995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin Downregulates the Transcriptional Coregulator CITED2, an Inhibitor of Proangiogenic Function in Endothelial Cells.
    Wang X; Lockhart SM; Rathjen T; Albadawi H; Sørensen D; O'Neill BT; Dwivedi N; Preil SR; Beck HC; Dunwoodie SL; Watkins MT; Rasmussen LM; Rask-Madsen C
    Diabetes; 2016 Dec; 65(12):3680-3690. PubMed ID: 27561725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CITED2 is activated in ulcerative colitis and induces p53-dependent apoptosis in response to butyric acid.
    Yoshida T; Sekine T; Aisaki K; Mikami T; Kanno J; Okayasu I
    J Gastroenterol; 2011 Mar; 46(3):339-49. PubMed ID: 21165656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of autophagy as a treatment strategy for p53 wild-type acute myeloid leukemia.
    Folkerts H; Hilgendorf S; Wierenga ATJ; Jaques J; Mulder AB; Coffer PJ; Schuringa JJ; Vellenga E
    Cell Death Dis; 2017 Jul; 8(7):e2927. PubMed ID: 28703806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strain-induced mechanotransduction through primary cilia, extracellular ATP, purinergic calcium signaling, and ERK1/2 transactivates CITED2 and downregulates MMP-1 and MMP-13 gene expression in chondrocytes.
    He Z; Leong DJ; Zhuo Z; Majeska RJ; Cardoso L; Spray DC; Goldring MB; Cobelli NJ; Sun HB
    Osteoarthritis Cartilage; 2016 May; 24(5):892-901. PubMed ID: 26687824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aggressive acute myeloid leukemia in PU.1/p53 double-mutant mice.
    Basova P; Pospisil V; Savvulidi F; Burda P; Vargova K; Stanek L; Dluhosova M; Kuzmova E; Jonasova A; Steidl U; Laslo P; Stopka T
    Oncogene; 2014 Sep; 33(39):4735-45. PubMed ID: 24121269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A role for CITED2, a CBP/p300 interacting protein, in colon cancer cell invasion.
    Bai L; Merchant JL
    FEBS Lett; 2007 Dec; 581(30):5904-10. PubMed ID: 18054336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CITED2 in breast carcinoma as a potent prognostic predictor associated with proliferation, migration and chemoresistance.
    Minemura H; Takagi K; Sato A; Takahashi H; Miki Y; Shibahara Y; Watanabe M; Ishida T; Sasano H; Suzuki T
    Cancer Sci; 2016 Dec; 107(12):1898-1908. PubMed ID: 27627783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Superior anti-tumor activity of the MDM2 antagonist idasanutlin and the Bcl-2 inhibitor venetoclax in p53 wild-type acute myeloid leukemia models.
    Lehmann C; Friess T; Birzele F; Kiialainen A; Dangl M
    J Hematol Oncol; 2016 Jun; 9(1):50. PubMed ID: 27353420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CITED2 Restrains Proinflammatory Macrophage Activation and Response.
    Kim GD; Das R; Rao X; Zhong J; Deiuliis JA; Ramirez-Bergeron DL; Rajagopalan S; Mahabeleshwar GH
    Mol Cell Biol; 2018 Mar; 38(5):. PubMed ID: 29203644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pan-histone deacetylase inhibitor panobinostat sensitizes gastric cancer cells to anthracyclines via induction of CITED2.
    Regel I; Merkl L; Friedrich T; Burgermeister E; Zimmermann W; Einwächter H; Herrmann K; Langer R; Röcken C; Hofheinz R; Schmid R; Ebert MP
    Gastroenterology; 2012 Jul; 143(1):99-109.e10. PubMed ID: 22465428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.